Kawada Hiroshi

論文

Successful Treatment of Chronic Active Epstein-Barr Virus Infection Complicated by Cardiomyopathy in an Adult Patient.

Comparison of the Mutational Profile between BCL2- and BCL6-Rearrangement Positive Follicular Lymphoma.

TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy.

ALK-negative anaplastic large cell lymphoma with TP53 mutation developing during the administration of baricitinib for atopic dermatitis - A case report.

Mutations in the SARS-CoV-2 spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants.

Liposome-encapsulated progesterone efficiently suppresses B-lineage cell proliferation.

Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.

Acute myeloid leukemia with a ZMYND11::MBTD1 fusion gene following chemotherapy and radiotherapy for breast cancer: A case report.

[Disseminated toxoplasmosis after cord blood transplantation diagnosed at autopsy].

Impact of previous anthracycline therapy in patients with acute myeloid leukemia receiving venetoclax.

Association of CDKN2A/2B deletion with relapse after hematopoietic stem cell transplantation for acute lymphoblastic leukemia.

Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome.

Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements, Diffuse Large B-Cell Lymphoma with MYC-Rearrangement, and Diffuse Large B-Cell Lymphoma with MYC-Cluster Amplification.

Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma.

The multilobated morphology is still a better prognosis factor of diffuse large B-cell lymphoma in the R-CHOP era.

Risk factors for lower respiratory tract disease and outcomes in allogeneic hematopoietic stem cell transplantation recipients with influenza virus infection.

9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions.

Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma.

Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells.

Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia.

共同研究・競争的資金等の研究課題

Development of a novel minimally invasive treatment for refractory and therapy-resistant hematological malignancies using food extracts.

Development of less invasive treatment for central nervous system invasion of refractory hematologic malignancies.

Development of a novel low-invasive treatment against acute leukemia adopting enhancement of oxidative stress

Subacute phase-cytokine therapy for the regeneraton of infarcted brain tissue

Myocardial Regeneration by Cytokine-mobilized Bone Marrow Stem Cells

Human hematopoietic reconstitution bu a single hematopoietic stem cell using intra-bone marrow transplantation

Cell therapy using bone marrow-derived stem cells, the possibility of its application in regenerative medicine.

In vitro expension of hematopoietic stem cells

Flow cytometric analysis in hematological malignancies